Diabetes in Cushing syndrome: basic and clinical aspects

被引:146
作者
Mazziotti, Gherardo [1 ,2 ]
Gazzaruso, Carmine [3 ,4 ]
Giustina, Andrea [1 ]
机构
[1] Univ Brescia, Montichiari Hosp, Endocrine Serv, Dept Med & Surg Sci, I-25018 Brescia, Italy
[2] Carlo Poma Hosp, Dept Med, Endocrine Unit, I-46100 Mantua, Italy
[3] ICBM, Ctr Appl Clin Res CeRCA, Diabet Endocrine Metab Dis & Cardiovasc Prevent U, I-27029 Vigevano, Italy
[4] Policlin San Donato, IRCCS, Dept Internal Med, I-20097 Milan, Italy
关键词
INCREASED CARDIOVASCULAR RISK; INSULIN-RESISTANCE; GROWTH-HORMONE; SOMATOSTATIN RECEPTORS; INDUCED OSTEOPOROSIS; GLUCOSE-TOLERANCE; DOSE OCTREOTIDE; DISEASE; GLUCOCORTICOIDS; METABOLISM;
D O I
10.1016/j.tem.2011.09.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus is a frequent complication of Cushing syndrome (CS) which is caused by chronic exposure to glucocorticoid excess, either endogenous or exogenous, and that is characterized by several clinical symptoms such as central obesity, purple striae, proximal muscle weakness, acne, hirsutism and neuropsychological disturbances. Diabetes occurs as a consequence of an insulin-resistant state together with impaired insulin secretion which are induced by glucocorticoid excess. The management of patients with CS and diabetes mellitus includes the treatment of hyperglycemia and, when possible, the correction of glucocorticoid excess. This review focuses on the disorders of glucose metabolism in patients exposed to glucocorticoid excess, addressing both the pathophysiological aspects and the clinical and therapeutic implications.
引用
收藏
页码:499 / 506
页数:8
相关论文
共 72 条
[1]   Effects of chronic administration of PPAR-γ ligand rosiglitazone in Cushing's disease [J].
Ambrosi, B ;
Dall'Asta, C ;
Cannavò, S ;
Libé, R ;
Vigo, T ;
Epaminonda, P ;
Chiodini, L ;
Ferrero, S ;
Trimarchi, F ;
Arosio, M ;
Beck-Peccoz, P .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 151 (02) :173-178
[2]  
Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc19-S002, 10.2337/dc12-S064, 10.2337/dc23-S002, 10.2337/dc09-S062, 10.2337/dc18-S002]
[3]   Diagnosis and complications of Cushing's syndrome: A consensus statement [J].
Arnaldi, G ;
Angeli, A ;
Atkinson, AB ;
Bertagna, X ;
Cavagnini, F ;
Chrousos, GP ;
Fava, GA ;
Findling, JW ;
Gaillard, RC ;
Grossman, AB ;
Kola, B ;
Lacroix, A ;
Mancini, T ;
Mantero, F ;
Newell-Price, J ;
Nieman, LK ;
Sonino, N ;
Vance, ML ;
Giustina, A ;
Boscaro, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12) :5593-5602
[4]   Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy [J].
Ben-Shlomo, Anat ;
Schmid, Herbert ;
Wawrowsky, Kolja ;
Pichurin, Oxana ;
Hubina, Erika ;
Chesnokova, Vera ;
Liu, Ning-Ai ;
Culler, Michael ;
Melmed, Shlomo .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (11) :4342-4350
[5]   Prevalence of diabetes in acromegaly and Cushing's disease [J].
Biering, H ;
Knappe, G ;
Gerl, H ;
Lochs, H .
ACTA MEDICA AUSTRIACA, 2000, 27 (01) :27-31
[6]   Treatment of adrenocorticotropin-dependent Cushing's syndrome: A consensus statement [J].
Biller, B. M. K. ;
Grossman, A. B. ;
Stewart, P. M. ;
Melmed, S. ;
Bertagna, X. ;
Bertherat, J. ;
Buchfelder, M. ;
Colao, A. ;
Hermus, A. R. ;
Hofland, L. J. ;
Klibanski, A. ;
Lacroix, A. ;
Lindsay, J. R. ;
Newell-Price, J. ;
Nieman, L. K. ;
Petersenn, S. ;
Sonino, N. ;
Stalla, G. K. ;
Swearingen, B. ;
Vance, M. L. ;
Wass, J. A. H. ;
Boscaro, M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (07) :2454-2462
[7]   Treatment of Pituitary-Dependent Cushing's Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial [J].
Boscaro, M. ;
Ludlam, W. H. ;
Atkinson, B. ;
Glusman, J. E. ;
Petersenn, S. ;
Reincke, M. ;
Snyder, P. ;
Tabarin, A. ;
Biller, B. M. K. ;
Findling, J. ;
Melmed, S. ;
Darby, C. H. ;
Hu, K. ;
Wang, Y. ;
Freda, P. U. ;
Grossman, A. B. ;
Frohman, L. A. ;
Bertherat, J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (01) :115-122
[8]   Continuous Monitoring of Circadian Glycemic Patterns in Patients Receiving Prednisolone for COPD [J].
Burt, Morton G. ;
Roberts, Gregory W. ;
Aguilar-Loza, Norma R. ;
Frith, Peter ;
Stranks, Stephen N. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (06) :1789-1796
[9]   Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase in the liver via an extended glucocorticoid regulatory unit [J].
Cassuto, H ;
Kochan, K ;
Chakravarty, K ;
Cohen, H ;
Blum, B ;
Olswang, Y ;
Hakimi, P ;
Xu, C ;
Massillon, D ;
Hanson, RW ;
Reshef, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (40) :33873-33884
[10]   Apelin, diabetes, and obesity [J].
Castan-Laurell, Isabelle ;
Dray, Cedric ;
Attane, Camille ;
Duparc, Thibaut ;
Knauf, Claude ;
Valet, Philippe .
ENDOCRINE, 2011, 40 (01) :1-9